Bajaj Healthcare Ltd.

302.3

3.1 (1%)stock indicator image for upward trend

BAJAJHCARE Share Price
As on June 16, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap1,014 Cr
P/E Ratio22.24
Dividend Yield0.07 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open303
High304.2
NSE SymbolBAJAJHCARE
Close302.3
Low296.85
BSE Symbol539872
Previous Years High/Low
1 Year High552.6
3 Year High745
5 Year High745
1 Year Low272.35
3 Year Low263.3
5 Year Low257.45

Technicals


IndicatorsValueSignal
5-DMA295.81Bullish
10-DMA294.85Bullish
20-DMA297.82Bullish
50-DMA312.88Bearish
100-DMA324.36Bearish
200-DMA380.59Bearish

Historical Performance


1 Year
-41.4%
3 Years
-5.4%
5 Years
N/A
10 Years
N/A

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:-1.8
TTM:-43.3
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a moderate PE of 22.24, suggesting fair valuation relative to earnings.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -1.3%, indicating poor shareholder returns.
  • The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹1020 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹5426 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 567326.6
No. of Shares: 1877 (Approx)
Performance:-43.3%
P/L: ₹-432673.4
NIFTY Performance: -3.5%
1 day Top Gainers
SymbolChange%
SONATSOFTW311.25(20%)
FACT997.8(10%)
MMTC75.74(8%)
PGEL527.45(7%)
ABREL1315.7(6%)
1 Day Top Losers
SymbolChange%
GICRE358.4(-7%)
PTCIL17809(-5%)
NATIONALUM366.65(-4%)
AKUMS596.85(-4%)
RAMCOCEM882.15(-3%)
UNOMINDA1089.5(-3%)
VMM116.95(-3%)
HINDALCO982.4(-3%)

Top Performing Stocks from the same sector


Venus Remedies Ltd.

104.8%

1867.8

1 Month Performance

Bliss GVS Pharma Ltd.

62.8%

451.9

1 Month Performance

Beta Drugs Ltd.

48.6%

1890.3

1 Month Performance

Orchid Pharma Ltd.

47.1%

1048.15

1 Month Performance

Sun Pharma Advanced Research Company Ltd.

45.7%

238.41

1 Month Performance

Brooks Laboratories Ltd.

44%

67.12

1 Month Performance

Panacea Biotec Ltd.

41%

544.95

1 Month Performance

Rubicon Research Ltd.

40.7%

1351.6

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month